Anvisa aprova  primeiro genérico de semaglutida no Brasil episode artwork

EPISODE · Aug 18, 2026 · 5 MIN

Anvisa aprova primeiro genérico de semaglutida no Brasil

from Comentaristas · host CBN

A Anvisa aprovou o primeiro genérico de semaglutida do Brasil. O médico Luis Fernando Correia explicou que a farmacêutica EMS desenvolveu uma versão sintética da mesma molécula, produzida por síntese química, ou seja, combinando substâncias no laboratório, sem célula viva. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Aug 18, 2026

Embed this episode

NOW PLAYING

Anvisa aprova primeiro genérico de semaglutida no Brasil

0:00 5:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Comentaristas?

This episode is 5 minutes long.

When was this Comentaristas episode published?

This episode was published on August 18, 2026.

Can I download this Comentaristas episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!